Sherlock Biosciences Announces Two Upcoming December Conferences
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec 2, 2019--
Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced that it will attend the following two conferences in December:
About Sherlock Biosciences
Sherlock Biosciences is dedicated to making molecular diagnostics better, faster and more affordable through Engineering Biology platforms. The company is developing applications of SHERLOCK™, a CRISPR-based method to detect and quantify specific genetic sequences, and INSPECTR TM, a Synthetic Biology-based molecular diagnostics platform that is instrument free. SHERLOCK and INSPECTR can be used in virtually any setting without complex instrumentation, opening up a wide range of potential applications in areas including precision oncology, infection identification, food safety, at-home tests, and disease detection in the field. For more information visit Sherlock.bio.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191202005207/en/
CONTACT: Katie Engleman
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY
SOURCE: Sherlock Biosciences
Copyright Business Wire 2019.
PUB: 12/02/2019 08:30 AM/DISC: 12/02/2019 08:30 AM